GERD Drug and Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The GERD Drug and Devices Market was USD 5.21 billion in 2020 and is expected to reach USD 6.28 billion in 2028 and register a revenue CAGR of 2% during the forecast period 2022-2028.

Gastroesophageal reflux disease (GERD) is a condition in which the LES relaxes or does not function properly, causing gastric juice to reflux back into the esophagus, causing heartburn. There are many different causes of GERD, such as smoking, hiatus hernia, obesity, and stress. GERD is also experienced by women during pregnancy. If left untreated, GERD can lead to conditions such as edema of the esophagus known as esophagitis, Barrett’s esophagus, ulcers, and strictures of the esophagus. Depending on the severity of the disease, a treatment module is planned. The drug is used as a first-line drug line to treat early-stage GERD. If treatment is unresponsive, a variety of invasive and minimally invasive techniques are used to treat GERD.

Market Segments

By Drug Type

• H2 Receptor Antagonist
• Proton Pump Inhibitors (PPIs)
• Antacids

By Device Type

• MUSE – Medigus Ultrasonic Surgical Endostapler
• LINX Management System
• Stretta Therapy
• Bravo Reflux Testing System
• Digitrapper Reflux Testing System

Key Players

• Johnson & Johnson
• AstraZeneca PLC
• Takeda Pharmaceutical Company Limited
• Pfizer Inc.
• Novartis AG
• GlaxoSmithKline Plc
• Merck & CO., Inc.
• Boston Scientific Corporation
• Eisai Co., Ltd.
• Ironwood Pharmaceuticals, Inc.
• Addex Therapeutic
• Takeda Pharmaceutical Company Limited

Scope of the Report

The research study analyzes the global GERD Drug and Devices industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by GERD Drug and Devices Market Report

1. What was the GERD Drug and Devices Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of GERD Drug and Devices Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the GERD Drug and Devices Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.